Skip to main content

Table 1 Comparison of the basic characteristics of patients with EGC between the delayed bleeding group and the nonbleeding group

From: External validation of the BEST-J score and a new risk prediction model for ESD delayed bleeding in patients with early gastric cancer

 

Nonbleeding group

(n = 417)

Delayed bleeding group (n = 27)

χ2 or t value

P value

Age (years, mean ± SD)

63.08 ± 9.317

63.00 ± 12.175

0.041

0.135

Sex [n (%)]

  

0.177

0.674

 Male

293 (70.3)

20 (74.3)

  

 Female

124 (29.7)

7 (25.9)

  

Hypertension [n (%)]

  

0.073

0.787

 No

258 (61.9)

16 (59.3)

  

 Yes

159 (38.1)

11 (40.7)

  

Coronary heart disease [n (%)]

 

NA

1.000

 No

376 (90.2)

25 (92.6)

  

 Yes

41 (9.8)

2 (7.4)

  

Diabetes [n (%)]

  

NA

0.444

 No

341 (81.8)

24 (88.9)

  

 Yes

76 (18.2)

3 (11.1)

  

Anticoagulant medication history [n (%)]

 

NA

0.172

 No

415 (99.5)

26 (96.3)

  

 Yes

2 (0.5)

1 (0.2)

  

Antiplatelet medication history [n (%)]

 

NA

1.000

 No

376 (90.2)

25 (92.6)

  

 Yes

41 (9.8)

2 (7.4)

  

Antidepressant medication history [n (%)]

 

NA

0.223

 No

414 (99.3)

26 (96.3)

  

 Yes

3 (0.7)

1 (0.2)

  

Proprietary Chinese medicine history [n (%)]

NA

0.614

 No

402 (96.4)

27 (100.0)

  

 Yes

15 (3.6)

0 (0.0)

  

Smoking [n (%)]

 

4.072

0.044*

 No

252 (60.4)

11 (40.7)

  

 Yes

165 (39.6)

16 (59.3)

  

Drinking [n (%)]

 

1.904

0.168

 No

271 (65.0)

14 (51.9)

  

 Yes

146 (35.0)

13 (48.1)

  

Family history of digestive tract tumors [n (%)]

1.188

0.276

 No

317 (76.0)

23 (85.2)

  

 Yes

100 (24.0)

4 (14.8)

  
  1. EGC, early gastric cancer; NA, not available due to Fisher’s exact test; SD, standard deviation
  2. *P < 0.05